Government Decision No. 73-N establishing the Procedure for authorizing advertising of veterinary vaccines, serums and diagnostics.

This Decision primarily addresses the regulation of advertising activities related to veterinary drugs, establishing a legal framework for granting, modifying, and revoking advertising permits. It operates within the broader context of the national legal and policy efforts to control the promotion of veterinary drugs, referencing relevant laws and general advertising legislation. The primary objective is to define procedures, requirements, and responsibilities for obtaining and managing advertising permits for veterinary vaccines, serum, and diagnostic tools, emphasizing compliance with product registration data and usage instructions. Key measures include the issuance of advertising permits by the Ministry of Economy based on submitted applications, which must contain detailed information about the applicant, the veterinary product, and the intended advertising medium. The document specifies the necessary documentation, such as the advertising text, registration certificates, and authorization documents, along with procedures for submitting applications via various channels. It also delineates conditions under which permits can be suspended or revoked, including non-compliance, falsified documents, or violations of relevant laws. The process involves a review period of up to 10 working days, with explicit instructions for handling discrepancies and the grounds for permit denial. Implementation mechanisms involve the assignment of responsibilities to the Ministry of Economy, with detailed timelines for permit issuance, modification, and revocation. The procedures include formal documentation, numbering, and record-keeping, with provisions for stakeholder notification and appeal processes. Enforcement is supported by procedural rules for suspension and cancellation of permits, emphasizing adherence to legal standards and the importance of accurate documentation. The document underscores the importance of transparency, procedural correctness, and compliance with established legal and regulatory requirements in the advertising of veterinary drugs.